Table 2.
Mendelian Randomization assessments regarding the connection between genetically instrumented immune cells and GBM.
Outcome | Exposure | Method | OR | 95% CI | P-value |
---|---|---|---|---|---|
GBM | CD45 on CD33+ HLA DR+ CD14dim | MR Egger | 1.263 | (0.936–1.703) | 0.150 |
Weighted median | 1.359 | (1.013–1.823) | 0.041 | ||
IVW | 1.307 | (1.072–1.595) | 0.008 | ||
Simple mode | 1.216 | (0.767–1.927) | 0.420 | ||
Weighted mode | 1.331 | (0.977–1.812) | 0.091 | ||
BWMR | 1.344 | (1.073–1.683) | 0.010 | ||
GBM | CD33+ HLA DR+ absolute count | MR Egger | 0.852 | (0.762–0.953) | 0.009 |
Weighted median | 0.869 | (0.751–1.006) | 0.060 | ||
IVW | 0.894 | (0.815–0.981) | 0.018 | ||
Simple mode | 0.981 | (0.785–1.227) | 0.868 | ||
Weighted mode | 0.900 | (0.794–1.019) | 0.107 | ||
BWMR | 0.880 | (0.784–0.989) | 0.032 | ||
GBM | IgD+ CD24+ B cell absolute count | MR Egger | 1.377 | (0.775–2.445) | 0.288 |
Weighted median | 1.495 | (0.945–2.366) | 0.086 | ||
IVW | 1.357 | (1.000–1.840) | 0.050 | ||
Simple mode | 2.043 | (0.987–4.229) | 0.067 | ||
Weighted mode | 1.555 | (0.922–2.634) | 0.112 | ||
BWMR | 1.375 | (0.966–1.957) | 0.077 |